Characterizing PAI-1 Modulation on Monocyte Adhesion

Stopped early

Conditions studied: Atherosclerosis

In brief

To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.

Key facts

Study ID

NCT00512031

Run by

Vanderbilt University

People needed

50

Starts

2007-01-01

Expected to finish

2011-07-01

Last updated by the study team

2011-07-18

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ages 18-50
• No current or past medical problems

You may not qualify if…

• Patients taking prescription drugs (hormonal birth control or herbal supplements may be taken)

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.